CRT-D May Reap Higher CE Ratio Than Defibrillation Alone – Annals Editorial
This article was originally published in The Gray Sheet
Executive Summary
Implantable cardioverter defibrillators with resynchronization (CRT-D) are likely to prove more cost-effective than ICD therapy alone for patients with moderate-to-severe heart failure, according to Stephen Pauker, MD, et al., Tufts University